Hypervolemia, arterial hypertension and cardiovascular disease: A largely neglected problem in peritoneal dialysis

Clinical Nephrology

Volumn 69, Issue 4, 2008, Pages 233-238

  Brunkhorst, Reinhard ^a  

^a Klinikum Hannover   (Germany)

Author keywords

Arterial hypertension; Cardiovascular disease; Hypervolemia; Residual renal function; Salt intake

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; ICODEXTRIN;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIET THERAPY; FLUID INTAKE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; PERITONEAL DIALYSIS; QUALITY OF LIFE; RESIDUAL URINE; REVIEW; SODIUM RESTRICTION; ULTRAFILTRATION;

EID: 42049118511     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP69233     Document Type: Review

References (43)

1. Amann K, Mandelbaum A, Schwarz U, Ritz E. Hypertension and left ventricular hypertrophy in the CAPD patient. Kidney Int. 1996; 56: S37-S40.
2. Bargman JM. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996; 7: 198-202.
3. Bargman JM, Thorpe KE, Churchill DN, CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001; 12: 2158-2162.
4. Canadian Organ Replacement Register 1991 Annual Report. Ontario: Dons Mills Hospital Medical Records Institute; 1993.
5. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients. Importance of the lag phenomenon. Am J Kidney Dis. 1989; 32: 720-724.
6. Cocchi R, Esposti ED, Fabbri A, Lucatello A, Sturani A, Quarello F et al. Prevalence of hypertension in patients on peritoneal dialysis; results of an Italian multicentre study. Nephrol Dial Transplant. 1999; 14: 1536-1540.
7. Davies SJ, Phillips L, Maish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001; 12: 1046-1051.
8. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann HP, Heimburger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind, randomized controlled trial. J Am Soc Nephrol. 2003; 14: 2338-2344.
9. Davies S. Overfill or ultrafiltration? We need to be clear. Perit Dial Int. 2006; 6: 449-451.
10. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S et al. Long-term CAPD patients are volume-expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant. 2001; 16: 1459-1464.
11. Faller B, Lameire N. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant. 1994; 9: 280-286.
12. Gunal AI, Duamnn S, Ozkahya M et al. Strict volume control normalises hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001; 37: 588-593.
13. Gunal AI, Kirciman E, Guler M, Yavuzkir M, Celiker H. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients? Ren Fail. 2004; 26: 405-409.
14. Guyton AC. Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens. 1989; 2: 575-585.
15. Guyton AC, Coleman TG. Quantitative analysis of the pathophysiology of hypertension. J Am Soc Nephrol. 1999; 10: 2248-2258.
16. Jager KJ, Merkus MP, Boeschoten EW, Dekker FW, Tijssen JG, Krediet RT. Necosad Study Group. What happens to patients starting dialysis in the Netherlands? Neth J Med. 2001; 58: 163-173.
17. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JGP, Stevens P, Bos WJW, Krediet RT. Determinants of mortality and technique faure in patients starting chronic peritoneal dialysis: Results of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD). Kidney Int. 1999; 55: 1476-1485.
18. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G. Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis. 2002; 39: 872-875.
19. Khandelwal M, Oreopoulos DG. Is there a need for low sodium dialysis solution for peritoneal dialysis patients? Adv Perit Dial. 2004; 20: 156-162.
20. Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant. 2002; 17: 1661-1666.
21. Konings CJAM. Dammers R, Rensma PL, Kooman JP, Hoeks APD, Kornet L, Gladziwa U, van der Sande FM, Leunissen KML. Arterial wall properties in patients with renal failure. Am J Kidney Dis. 2002; 39: 1206-1212.
22. Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant. 1998; 13: 552-553.
23. Krediet RT. Dry body weight: water and sodium removal targets in PD. Contrib Nephrol. 2006; 150: 104-110.
24. La Milia VL, Pozzoni P, Crepaldi M, Locatelli F. Overfilling of dialysis bags as a cause of underestimation of ultrafiltration failure. Perit Dial Int. 2006; 26: 503-504.
25. Levy D, Garrison RJ, Savage DD et al. Prognostic implication of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1999; 322: 1561-1566.
26. McCormick BB, Bargman JM. The implications of the ADEMEX study for the peritoneal dialysis prescription: the role of small solute clearance versus salt and water removal. Current Opinion in Nephrology and Hypertension. 2003; 12: 581-585.
27. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant. 2001; 16: 2207-2213.
28. Milutinovic J, Cutler R, Hoover P, Meijsen B, Scribner B. Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int. 1975; 8: 185-190.
29. Nakayama M, Yokoyama K, Kubo H et al. The effect of ultralow sodium dialysate in CAPD. A kinetic and clinical analysis. Clin Nephrol. 1996; 45: 188-193.
30. National Heart Lung and Blood Institutes. Morbidity and Mortality Chartbook. Bethesda, MD: National Heart Lung and Blood Institute; 1996.
31. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, Peeters J, Freida P, Struijk DG, Krediet RT, Grabensee B, Tranaeus A, Filho JC. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis. 2002; 39: 862-871.
32. Rahman M, Dixit A, Donley V et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis. 1999; 33: 498-506.
33. Rocco MV, Flanigan MJ, Beaver S et al. Report from the 1995 core indicators for peritoneal dialysis study group. Am J Kidney Dis. 1997; 30: 165-173.
34. Rodriguez-Carmona A, Perez-Fontan M, Garca-Naveiro R, Villaverde P, Peteiro J. Compared time profiles of ultrafiltration, sodium removal and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis. 2004; 44: 132-145.
35. Saldhana L, Weiler EWJ, Gonick HC. Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis. 1993; 21: 184-188.
36. Shaldon S. Dietary salt restriction and drug-free treatment of hypertension in ESRD patients: a largely abandoned therapy. Nephrol Dial Transplant. 2002; 17: 1163-1165.
37. Shaldon S. An explanation for the "lag phenomenon" in drug-free control of hypertension by dietary salt restriction in patients with chronic kidney disease on hemodialysis. Clin Nephrol. 2006; 66: 1-2.
38. Takeda K, Nakamoto M, Hirakata H, Baba M, Kubo M, Fujishima M. Disadvantage of long-term CAPD for preserving cardiac performance: an echocardiographic study. Am J Kidney Dis. 1998; 32: 482-487.
39. + storage in the skin. Am J Physiol Heart Circ Physiol. 2004; 287: H203-H208.
40. United States Renal Data System. USRDS 2000 Annual Data Report. Bethesda, MD: Department of Health and Human Services, The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2000.
41. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int. 2002; 62: 639-647.
42. Wang AY. The John F Maher Award Recipient Lecture 2006. The "heart" of peritoneal dialysis: residual renal function. Perit Dial Int. 2007; 27: 116-124.
43. Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedace analysis. Nephrol Dial Transplant. 2000; 15: 862-866.